New drug combo shows promise for controlling lymphoma
NCT ID NCT02180711
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests a drug called acalabrutinib, alone or with other medicines, in 113 adults with B-cell non-Hodgkin lymphoma that has come back or not responded to prior treatment. The goal is to see if the drug is safe and shrinks tumors. This is an early-phase trial, so it focuses on safety and initial effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Tucson, Arizona, 85719, United States
-
Research Site
Downey, California, 90241, United States
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Fountain Valley, California, 92708, United States
-
Research Site
Santa Monica, California, 90404, United States
-
Research Site
Coral Gables FL, Florida, 33146, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Chicago, Illinois, 60612, United States
-
Research Site
Chicago, Illinois, 60637, United States
-
Research Site
Louisville, Kentucky, 40207, United States
-
Research Site
New Orleans, Louisiana, 70112, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Morristown, New Jersey, 07960, United States
-
Research Site
Hawthorne, New York, 10532, United States
-
Research Site
Lake Success, New York, 11042, United States
-
Research Site
New York, New York, 10021, United States
-
Research Site
Syracuse, New York, 13210, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Greenville, South Carolina, 29615, United States
-
Research Site
Dallas, Texas, 75235, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
San Antonio, Texas, 78217, United States
-
Research Site
Temple, Texas, 76508, United States
-
Research Site
Salt Lake City, Utah, 84112, United States
-
Research Site
Spokane, Washington, 99208, United States
-
Research Site
Waukesha, Wisconsin, 53188, United States
-
Research Site
Edmonton, Alberta, t6G1Z2, Canada
-
Research Site
London, Ontario, N6A 5W9, Canada
-
Research Site
Toronto, Ontario, M5G 2M9, Canada
-
Research Site
Bologna, 40138, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Palermo, 90146, Italy
Conditions
Explore the condition pages connected to this study.